Welcome to the complex disease world: Alpha2-macroglobulin and Alzheimer's disease

Experimental Neurology

Volumn 184, Issue 1, 2003, Pages 50-53

  Saunders, Aleister J ^a   Tanzi, Rudolph E ^b  

^a DREXEL UNIVERSITY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 MACROGLOBULIN; AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; DNA POLYMORPHISM; GENE DELETION; GENE MUTATION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; NOTE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; RNA SPLICING;

EID: 0344826517     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.expneurol.2003.09.004     Document Type: Note

References (39)

1. Alvarez V., Alvarez R., Lahoz C.H., Martinez C., Pena J., Guisasola L.M., Salas-Puig J., Moris G., Uria D., Menes B.B., Ribacoba R., Vidal J.A., Sanchez J.M., Coto E. Association between an alpha(2) macroglobulin DNA polymorphism and late-onset Alzheimer's disease. Biochem. Biophys. Res. Commun. 264:1999;48-50.
2. Birkenmeier, G., Muller, R., Huse, K., Forberg, J., Glaser, C., Hedrich, H., Nicklisch, S., Reichenbach, A., 2003. Human alpha2-macroglobulin: genotype-phenotype relation. Exp. Neurol. 184, 153-161.
3. Blacker D., Crystal A.S., Wilcox M.A., Laird N.M., Tanzi R.E. In Reply. Nat. Genet. 22:1999;21-22.
4. Blacker D., Haines J.L., Rodes L., Terwedow H., Go R.C., Harrell L.E., Perry R.T., Bassett S.S., Chase G., Meyers D., Albert M.S., Tanzi R. ApoE-4 and age at onset of Alzheimer's disease the NIMH genetics initiative. Neurology. 48:1997;139-147.
5. Blacker D., Wilcox M.A., Laird N.M., Rodes L., Horvath S.M., Go R.C., Perry R., Watson B. Jr., Bassett S.S., McInnis M.G., Albert M.S., Hyman B.T., Tanzi R.E. Alpha-2 macroglobulin is genetically associated with Alzheimer disease. Nat. Genet. 19:1998;357-360.
6. Daw E.W., Payami H., Nemens E.J., Nochlin D., Bird T.D., Schellenberg G.D., Wijsman E.M. The number of trait loci in late-onset Alzheimer disease. Am. J. Hum. Genet. 66:2000;196-204.
7. Dodel R.C., Du Y., Bales K.R., Gao F., Eastwood B., Glazier B., Zimmer R., Cordell B., Hake A., Evans R., Gallagher-Thompson D., Thompson L.W., Tinklenberg J.R., Pfefferbaum A., Sullivan E.V., Yesavage J., Alstiel L., Gasser T., Farlow M.R., Murphy G.M. Jr., Paul S.M. Alpha2 macroglobulin and the risk of Alzheimer's disease. Neurology. 54:2000;438-442.
8. Du Y., Bales K.R., Dodel R.C., Liu X., Glinn M.A., Horn J.W., Little S.P., Paul S.M. Alpha2-macroglobulin attenuates beta-amyloid peptide 1-40 fibril formation and associated neurotoxicity of cultured fetal rat cortical neurons. J. Neurochem. 70:1998;1182-1188.
9. Du Y., Ni B., Glinn M., Dodel R.C., Bales K.R., Zhang Z., Hyslop P.A., Paul S.M. Alpha2-macroglobulin as a beta-amyloid peptide-binding plasma protein. J. Neurochem. 69:1997;299-305.
10. Haass C., De Strooper B. The presenilins in Alzheimer's disease - proteolysis holds the key. Science. 286:1999;916-919.
11. Hardy J. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci. 20:1997;154-159.
12. Hughes S.R., Khorkova O., Goyal S., Knaeblein J., Heroux J., Riedel N.G., Sahasrabudhe S. Alpha2-macroglobulin associates with beta-amyloid peptide and prevents fibril formation. Proc. Natl. Acad. Sci. USA. 95:1998;3275-3280.
13. Jhoo J.H., Kim K.W., Lee D.Y., Lee K.U., Lee J.H., Kim S.Y., Youn J.Y., Youn J.C., Woo J.I. Association of alpha-2-macroglobulin deletion polymorphism with sporadic Alzheimer's disease in Koreans. J. Neurol. Sci. 184:2001;21-25.
14. Lauer D., Reichenbach A., Birkenmeier G. Alpha 2-macroglobulin-mediated degradation of amyloid beta 1 - 42 a mechanism to enhance amyloid beta catabolism. Exp. Neurol. 167:2001;385-392.
15. Liao A., Nitsch R.M., Greenberg S.M., Finckh U., Blacker D., Albert M., Rebeck G.W., Gomez-Isla T., Clatworthy A., Binetti G., Hock C., Mueller-Thomsen T., Mann U., Zuchowski K., Beisiegel U., Staehelin H., Growdon J.H., Tanzi R.E., Hyman B.T. Genetic association of an alpha2-macroglobulin (Val1000Ile) polymorphism and Alzheimer's disease. Hum. Mol. Genet. 7:1998;1953-1956.
16. Mayeux R., Lee J.H., Romas S.N., Mayo D., Santana V., Williamson J., Ciappa A., Rondon H.Z., Estevez P., Lantigua R., Medrano M., Torres M., Stern Y., Tycko B., Knowles J.A. Chromosome-12 mapping of late-onset Alzheimer disease among Caribbean Hispanics. Am. J. Hum. Genet. 70:2002;237-243.
17. Meyer M.R., Tschanz J.T., Norton M.C., Welsh-Bohmer K.A., Steffens D.C., Wyse B.W., Breitner J.C. APOE genotype predicts when - not whether - one is predisposed to develop Alzheimer disease. Nat. Genet. 19:1998;321-322.
18. Myers A., Wavrant De-Vrieze F., Holmans P., Hamshere M., Crook R., Compton D., Marshall H., Meyer D., Shears S., Booth J., Ramic D., Knowles H., Morris J.C., Williams N., Norton N., Abraham R., Kehoe P., Williams H., Rudrasingham V., Rice F., Giles P., Tunstall N., Jones L., Lovestone S., Williams J., Owen M.J., Hardy J., Goate A. Full genome screen for Alzheimer disease stage II analysis. Am. J. Med. Genet. 114:2002;235-244.
19. Myllykangas L., Polvikoski T., Sulkava R., Verkkoniemi A., Crook R., Tienari P.J., Pusa A.K., Niinisto L., O'Brien P., Kontula K., Hardy J., Haltia M., Perez-Tur J. Genetic association of alpha2-macroglobulin with Alzheimer's disease in a Finnish elderly population. Ann. Neurol. 46:1999;382-390.
20. Nacmias B., Tedde A., Cellini E., Forleo P., Orlacchio A., Guarnieri B.M., Petruzzi C., D'Andrea F., Serio A., Sorbi S. Alpha2-macroglobulin polymorphisms in Italian sporadic and familial Alzheimer's disease. Neurosci. Lett. 299:2001;9-12.
21. Narita M., Holtzman D.M., Schwartz A.L., Bu G. Alpha2-macroglobulin complexes with and mediates the endocytosis of beta-amyloid peptide via cell surface low-density lipoprotein receptor-related protein. J. Neurochem. 69:1997;1904-1911.
22. Pericak-Vance M.A., Bass M.P., Yamaoka L.H., Gaskell P.C., Scott W.K., Terwedow H.A., Menold M.M., Conneally P.M., Small G.W., Vance J.M., Saunders A.M., Roses A.D., Haines J.L. Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12. JAMA. 278:1997;1237-1241.
23. Price D.L., Tanzi R.E., Borchelt D.R., Sisodia S.S. Alzheimer's disease genetic studies and transgenic models. Annu. Rev. Genet. 32:1998;461-493.
24. Rogaeva E.A., Premkumar S., Grubber J., Serneels L., Scott W.K., Kawarai T., Song Y., Hill D.L., Abou-Donia S.M., Martin E.R., Vance J.J., Yu G., Orlacchio A., Pei Y., Nishimura M., Supala A., Roberge B., Saunders A.M., Roses A.D., Schmechel D., Crane-Gatherum A., Sorbi S., Bruni A., Small G.W., Pericak-Vance M.A., et al. An alpha-2-macroglobulin insertion-deletion polymorphism in Alzheimer disease. Nat. Genet. 22:1999;19-22.
25. Rogaeva E., Premkumar S., Song Y., Sorbi S., Brindle N., Paterson A., Duara R., Levesque G., Yu G., Nishimura M., Ikeda M., O'Toole C., Kawarai T., Jorge R., Vilarino D., Bruni A.C., Farrer L.A., St. George-Hyslop P.H. Evidence for an Alzheimer disease susceptibility locus on chromosome 12 and for further locus heterogeneity. JAMA. 280:1998;614-618.
26. Romas S.N., Mayeux R., Rabinowitz D., Tang M.X., Zadroga H.R., Lantigua R., Medrano M., Tycko B., Knowles J.A. The deletion polymorphism and Val1000Ile in alpha-2-macroglobulin and Alzheimer disease in Caribbean Hispanics. Neurosci. Lett. 279:2000;133-136.
27. Rudrasingham V., Wavrant-De Vrieze F., Lambert J.C., Chakraverty S., Kehoe P., Crook R., Amouyel P., Wu W., Rice F., Perez-Tur J., Frigard B., Morris J.C., Carty S., Petersen R., Cottel D., Tunstall N., Holmans P., Lovestone S., Chartier-Harlin M.C., Goate A., Hardy J., Owen M.J., Williams J. Alpha-2 macroglobulin gene and Alzheimer disease. Nat. Genet. 22:1999;17-19. discussion 21-12.
28. Saunders, A.J., Bertram, L., Mullin, K., Sampson, A.J., Basu, S., Jones, J., Kinney, D., MacKenzie-Ingano, L., Yu, S., Albert, M., Moscarillo, T.J., Go, R.C., Bassett, S.S., Daly, M.J., Laird, N., Becker, D.K., Wang, G., Velicelebi, G., Tanzi, R.E., Blacker, D., 2003. Genetic association of Alzheimer's disease with multiple polymorphisms in alpha-2-macroglobulin. Hum. Genet. (In press).
29. Saunders A.M., Strittmatter W.J., Schmechel D., George-Hyslop P.H., Pericak-Vance M.A., Joo S.H., Rosi B.L., Gusella J.F., Crapper-MacLachlan D.R., Alberts M.J., et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 43:1993;1467-1472.
30. Scott W.K., Grubber J.M., Abou-Donia S.M., Church T.D., Saunders A.M., Roses A.D., Pericak-Vance M.A., Conneally P.M., Small G.W., Haines J.L. Further evidence linking late-onset Alzheimer disease with chromosome 12. JAMA. 281:1999;513-514.
31. Scott W.K., Grubber J.M., Conneally P.M., Small G.W., Hulette C.M., Rosenberg C.K., Saunders A.M., Roses A.D., Haines J.L., Pericak-Vance M.A. Fine mapping of the chromosome 12 late-onset Alzheimer disease locus potential genetic and phenotypic heterogeneity. Am. J. Hum. Genet. 66:2000;922-932.
32. Slaugenhaupt S.A., Blumenfeld A., Gill S.P., Leyne M., Mull J., Cuajungco M.P., Liebert C.B., Chadwick B., Idelson M., Reznik L., Robbins C., Makalowska I., Brownstein M., Krappmann D., Scheidereit C., Maayan C., Axelrod F.B., Gusella J.F. Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia. Am. J. Hum. Genet. 68:2001;598-605.
33. Tang G., Zhang M., Xie H., Jiang S., Wang Z., Xu L., Hao Y., Lin D., Lan H., Wang Y., Chen L., Ren D. Alpha-2 macroglobulin I1000 V polymorphism in Chinese sporadic Alzheimer's disease and Parkinson's disease. Neurosci. Lett. 328:2002;195-197.
34. Tanzi R.E. A genetic dichotomy model for the inheritance of Alzheimer's disease and common age-related disorders. J. Clin. Invest. 104:1999;1175-1179.
35. Tanzi R.E., Bertram L. New frontiers in Alzheimer's disease genetics. Neuron. 32:2001;181-184.
36. Wang X., Luedecking E.K., Minster R.L., Ganguli M., DeKosky S.T., Kamboh M.I. Lack of association between alpha2-macroglobulin polymorphisms and Alzheimer's disease. Hum. Genet. 108:2001;105-108.
37. Wavrant-DeVrieze F., Rudrasingham V., Lambert J.C., Chakraverty S., Kehoe P., Crook R., Amouyel P., Wu W., Holmans P., Rice F., Perez-Tur J., Frigard B., Morris J.C., Carty S., Cottel D., Tunstall N., Lovestone S., Petersen R.C., Chartier-Harlin M.C., Goate A., Owen M.J., Williams J., Hardy J. No association between the alpha-2 macroglobulin I1000V polymorphism and Alzheimer's disease. Neurosci. Lett. 262:1999;137-139.
38. Wu W.S., Holmans P., Wavrant-DeVrieze F., Shears S., Kehoe P., Crook R., Booth J., Williams N., Perez-Tur J., Roehl K., Fenton I., Chartier-Harlin M.C., Lovestone S., Williams J., Hutton M., Hardy J., Owen M.J., Goate A. Genetic studies on chromosome 12 in late-onset Alzheimer disease. JAMA. 280:1998;619-622.
39. Zappia M., Cittadella R., Manna I., Nicoletti G., Andreoli V., Bonavita S., Gambardella A., Quattrone A. Genetic association of alpha2-macroglobulin polymorphisms with AD in southern Italy. Neurology. 59:2002;756-758.